12-Jun-2007 - After dismal second quarter results Patheon is stepping up its resolve for 'damage control' and indicated that further cutbacks at its problematic Puerto Rico plant are imminent.
11-Jun-2007 - The fallout from a US Food and Drug Administration (FDA) probe continues to haunt MDS Pharma, dragging it into the red again during the second quarter.
07-Jun-2007 - Applied Biosystems has entered into a four-year supply agreement with Repligen to receive recombinant Protein A.
06-Jun-2007 - Morphotek, CMC Biopharmaceuticals, Cobra Biomanufacturing, and Fraunhofer have all announced new contract manufacturing deals this week.
05-Jun-2007 - Denmark-based Bavarian Nordic has clocked up a whopping $500m (€371m) contract with the US government to supply millions of doses of smallpox vaccine.
05-Jun-2007 - A new approach to Phase I clinical trials could revolutionise drug development, enabling innovative drugs to get to market faster and cheaper.
04-Jun-2007 - Analysing the images from protein separation experiments, such as 2D gel electrophoresis (2DGE), is not only time consuming but can often miss 'hits' and give false positives. But it doesn't have to be that way, according to Swedish company Ludesi.
30-May-2007 - The fine chemicals division of Japanese contract manufacturer Daiso has taken out a license to a highly-selective technology used to synthesise chiral molecules.
29-May-2007 - Contract manufacturing organisations (CMOs) have been pinpointed as a growth driver of single-use biopharmaceutical manufacturing technologies.
29-May-2007 - GlaxoSmithKline (GSK) is the latest pharma heavyweight to set up a drug research centre in China.
24-May-2007 - UK biotech firm Acambis has decided to bring the manufacturing of its soon to be approved smallpox vaccine in-house while its agreement with contract manufacturer Baxter comes to an end.
23-May-2007 - Canada-based Draxis Health has passed a US Food and Drug Administration (FDA) inspection with flying colours after contracting out its manufacturing services to two new clients.
23-May-2007 - The first contract research service alliance (CROSA) in China has been formed between three leading local firms to provide a more exhaustive range of drug development services to pharma companies.
23-May-2007 - A non-invasive technique that uses hair plucked from cancer patients to guide the development of new chemotherapy drugs has attracted the attention of UK pharma giant AstraZeneca.
22-May-2007 - Eden Biodesign, the biopharmaceutical development and manufacturing services company that runs the UK's National Biomanufacturing Centre (NBC), has now been cleared to produce investigational medicinal products for clinical trials at its facility in Speke, Liverpool.
21-May-2007 - Anglo-German firm Evotec is taking its fragment-based drug discovery (FBDD) services a step further with the launch today of a new innovation centre for FBDD.
21-May-2007 - The significance of the aborted deal between GlaxoSmithKline and Cobra has been exaggerated due to GSK's high profile and is not the end of the world, the British contract manufacturer said.
17-May-2007 - Massachusetts-based Avecia OligoMedicines has announced an expansion of its manufacturing facilities to accommodate increased production plans.
17-May-2007 - Swiss contract manufacturer Lonza has decided to merge its US microbial biopharma business activities in a single location, three months after buying Cambrex's biopharma unit.
16-May-2007 - Contract manufacturer Granules India is moving towards vertical integration, with a new tabletting facility scheduled to come onstream this August at the company's Gagillapur site near Hyderabad in India.
16-May-2007 - Outsourced pharmaceutical R&D spending is set to increase at twice the expected rate of general R&D expenditure for the next five years, according to new research published this week.
14-May-2007 - In this week's review of activity within the preclinical research services arena, new deals have emerged involving Gene Bridges, Panacos Pharmaceuticals, and GenScript.
10-May-2007 - Lonza is betting on the growth of antibody-drug conjugates as the way-of-the-future cancer treatments by moving to large scale production of the emerging drug class by 2008.
10-May-2007 - Charles River has posted first quarter results that beat analysts expectations after seeing renewed growth in its research models and services segment.
09-May-2007 - Clariant has cut its ties with the life sciences industry and will no longer offer custom manufacturing services in this arena after the sale of the last piece of its Lifesciences division.